• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性凝血酶原血症:一种人类凝血酶原的遗传性结构紊乱。

Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin.

作者信息

Shapiro S S, Martinez J, Holburn R R

出版信息

J Clin Invest. 1969 Dec;48(12):2251-9. doi: 10.1172/JCI106191.

DOI:10.1172/JCI106191
PMID:5355338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC297482/
Abstract

A large family has been studied, 11 of whose members have half-normal plasma concentrations of biological prothrombin activity. The pattern of inheritance is autosomal. By use of a specific immunoassay, affected family members have been shown to possess normal quantities of immunoreactive prothrombin, whose immunologic properties seem identical with those of the normal zymogen. Prothrombin isolation from the plasma of one such individual gave normal yields of protein but half-normal amounts of prothrombin activity. Activation of this material in the "intrinsic" and "extrinsic" systems, in concentrated sodium citrate, or by trypsin, gives rise to half, or less, of the thrombin clotting and esterase activities expected from a comparable normal prothrombin preparation. During the clotting of blood from an affected individual, all material with the mobility of prothrombin disappears. Immunoelectrophoresis of the serum reveals a normal nonthrombin "pro piece," and an additional activation product with an electrophoretic mobility intermediate between that of prothrombin and of "pro piece." These results suggest that affected individuals are heterozygotes in whom half the prothrombin molecules synthesized are structurally abnormal, since they undergo some alterations during activation, but are incapable of releasing the active enzyme, thrombin.

摘要

对一个大家庭进行了研究,该家庭中有11名成员的血浆中生物凝血酶原活性浓度为正常水平的一半。其遗传模式为常染色体遗传。通过使用一种特定的免疫测定法,已证明受影响的家庭成员拥有正常数量的免疫反应性凝血酶原,其免疫学特性似乎与正常酶原相同。从其中一名个体的血浆中分离凝血酶原,得到的蛋白质产量正常,但凝血酶原活性只有正常水平的一半。在“内源性”和“外源性”系统中,在浓缩柠檬酸钠中或用胰蛋白酶激活这种物质时,产生的凝血酶凝血和酯酶活性只有正常凝血酶原制剂预期活性的一半或更低。在受影响个体的血液凝固过程中,所有具有凝血酶原迁移率的物质都会消失。血清的免疫电泳显示出正常的非凝血酶“前体片段”,以及一种额外的激活产物,其电泳迁移率介于凝血酶原和“前体片段”之间。这些结果表明,受影响的个体是杂合子,其中合成的一半凝血酶原分子在结构上是异常的,因为它们在激活过程中会发生一些改变,但无法释放活性酶凝血酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/d56422e64b91/jcinvest00249-0081-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/179357a02f11/jcinvest00249-0077-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/aa0e30675c33/jcinvest00249-0078-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/44ab0c3b4c3c/jcinvest00249-0079-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/d43bd049a2fa/jcinvest00249-0080-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/d56422e64b91/jcinvest00249-0081-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/179357a02f11/jcinvest00249-0077-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/aa0e30675c33/jcinvest00249-0078-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/44ab0c3b4c3c/jcinvest00249-0079-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/d43bd049a2fa/jcinvest00249-0080-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec5/297482/d56422e64b91/jcinvest00249-0081-a.jpg

相似文献

1
Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin.先天性凝血酶原血症:一种人类凝血酶原的遗传性结构紊乱。
J Clin Invest. 1969 Dec;48(12):2251-9. doi: 10.1172/JCI106191.
2
Prothrombin Perija: a new congenital dysprothrombinemia in an Indian family.
Thromb Res. 1986 Dec 1;44(5):587-98. doi: 10.1016/0049-3848(86)90161-1.
3
A new variant of human prothrombin: prothrombin Metz, demonstration in a family showing double heterozygosity for congenital hypoprothrombinemia and dysprothrombinemia.
Haemostasis. 1982;12(4):309-16. doi: 10.1159/000214689.
4
Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia.
Blood. 1996 Oct 1;88(7):2611-8.
5
Hereditary prothrombin deficiency.
N Engl J Med. 1970 Jan 8;282(2):57-61. doi: 10.1056/NEJM197001082820202.
6
Congenital deficiencies and abnormalities of prothrombin.凝血酶原的先天性缺陷与异常。
Blood Coagul Fibrinolysis. 1998 Oct;9(7):557-69. doi: 10.1097/00001721-199810000-00001.
7
Prothrombin Habana: a new dysfunctional molecule of human prothrombin associated with a true prothrombin deficiency.
Br J Haematol. 1983 Aug;54(4):553-60. doi: 10.1111/j.1365-2141.1983.tb02133.x.
8
Prothrombin Greenville, Arg517-->Gln, identified in an individual heterozygous for dysprothrombinemia.格林维尔凝血酶原,精氨酸517突变为谷氨酰胺,在一名凝血酶原血症杂合子个体中被鉴定出来。
Blood. 1998 Mar 15;91(6):2026-31.
9
Prothrombin San Antonio: a single amino acid substitution at a factor Xa activation site (Arg320 to His) results in dysprothrombinemia.
Blood. 2000 Jan 15;95(2):711-4.
10
A novel congenital dysprothrombinemia leading to defective prothrombin maturation.一种导致凝血酶原成熟缺陷的新型先天性凝血酶原血症。
Thromb Res. 2014 Nov;134(5):1135-41. doi: 10.1016/j.thromres.2014.08.028. Epub 2014 Sep 8.

引用本文的文献

1
Identification of a congenital dysthrombin, thrombin Quick.先天性异常凝血酶(凝血酶快速)的鉴定
J Clin Invest. 1980 Nov;66(5):934-40. doi: 10.1172/JCI109961.
2
Molecular deficiencies of human blood coagulation.人类血液凝固的分子缺陷
Experientia. 1972 Jan 15;28(1):1-7. doi: 10.1007/BF01928228.
3
Hereditary disorders of blood coagulation due to defective and deficient synthesis of protein.由于蛋白质合成缺陷和不足导致的遗传性血液凝固障碍。

本文引用的文献

1
Some properties of purified prothrombin and its activation with sodium citrate.纯化凝血酶原的一些特性及其柠檬酸钠激活作用
Blood. 1950 May;5(5):421-33.
2
[Mechanism of thrombin formation in the isolated system].[离体系统中凝血酶形成的机制]
Hoppe Seylers Z Physiol Chem. 1951;289(1):26-43.
3
Hereditary hypoprothrombinaemias.
Lancet. 1962 Jan 27;1(7222):173-7. doi: 10.1016/s0140-6736(62)91073-5.
Trans Am Clin Climatol Assoc. 1971;82:114-23.
4
Factor VIII immunological assay. An evaluation of several methods using whole plasma.凝血因子 VIII 免疫测定:使用全血对几种方法的评估
Blut. 1974 Nov;29(5):309-16. doi: 10.1007/BF01634015.
5
The effect of several viper venoms on prothrombin Padua.几种蝰蛇毒液对凝血酶原帕多瓦的影响。
Blut. 1975 Sep;31(3):155-60. doi: 10.1007/BF01634838.
6
An immunological investigation of factor VIII associated antigen in combined factor V and factor VIII deficiency.
Blut. 1976 Aug;33(2):97-102. doi: 10.1007/BF00999872.
4
A STUDY OF THREE CASES OF FAMILIAL CONGENITAL HYPOPROTHROMBINAEMIA (FACTOR II DEFICIENCY).
Thromb Diath Haemorrh. 1964 Jul 31;11:497-505.
5
[ANTI-FACTOR VIII CIRCULATING ANTICOAGULANTS DURING HEMOPHILIA A. (NATURE AND MECHANISM OF ACTION)].[血友病A患者体内的抗凝血因子VIII循环抗凝物质。(性质及作用机制)]
Nouv Rev Fr Hematol. 1963 Nov-Dec;3:703-22.
6
[Study of a case of congenital hypoprothrombinemia].
Nouv Rev Fr Hematol. 1962 Sep-Oct;2:647-72.
7
Severe congenital hypoprothrombinemia in a Negro boy.一名黑人男孩患严重先天性低凝血酶原血症。
Thromb Diath Haemorrh. 1962 Nov 15;8:235-40.
8
Immunochemical studies on proteins important in blood coagulation.关于血液凝固中重要蛋白质的免疫化学研究。
Thromb Diath Haemorrh. 1962 Oct 1;8:21-36.
9
Congenital hypofibrinogenemia in five members of a family.一个家族中五名成员的先天性低纤维蛋白原血症
Can Med Assoc J. 1963 Jan 5;88(1):19-22.
10
Preparation of human plasma prothrombin and some of its sedimentation properties.
J Biol Chem. 1963 Jan;238:238-43.